fbpx
QQQ
+ 4.25
359.70
+ 1.17%
DIA
+ 2.33
345.93
+ 0.67%
SPY
+ 4.31
431.15
+ 0.99%
TLT
-1.00
150.50
-0.67%
GLD
-0.56
169.65
-0.33%

First Commercial Import Of IMC Branded Medical Cannabis From Spain Landed In Israel

May 29, 2020 4:34 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
First Commercial Import Of IMC Branded Medical Cannabis From Spain Landed In Israel

IM Cannabis Corp (CSE:IMCC) (OTC:IMCNF), an Israel-based medical cannabis company with European operations, made history this week with the successful arrival of the first commercial shipment of its branded medical cannabis from the company’s strategic EU-GMP Spanish supplier Linneo Health.

The first batch already passed all the required local regulatory inspections and approvals to be sold to patients. It's expected to be available in the local market as early as June.

According to IM Cannabis, the agreement with Linneo Health also includes future supply to other European markets where IM Cannabis operates. It complements four domestic supply agreements IM Cannabis has with Israeli cultivators to fulfill multiple binding sales agreements the company secured with leading Israeli pharmacy chains for 33,000 Kg of its branded products.

Oren Shuster, CEO of IM Cannabis, is scheduled to speak at the Virtual Benzinga Cannabis Capital Conference this coming Monday.

"The successful commercial import of IMC branded medical cannabis products from the Spanish partner to Israel and later to other European markets is a key milestone that underpins our dual growth strategy for both domestic and international markets," Shuster said. "It also demonstrates our commitment and capability to supply high-quality medical cannabis products across international markets as we become a dominant player in the global medical cannabis industry.”

Photo by Ethan McArthur on Unsplash

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.

Posted-In:

Cannabis News Markets

Related Articles

IM Cannabis Expects Q2 Revenue At $11-12M, Completes State-Of-The-Art Logistics Center In Germany

Multi-country medical and recreational cannabis operator IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) provided its preliminary second-quarter revenue projections on Friday, as well as a third-quarter outlook and u read more

IM Cannabis Clinical Survey Reports Efficacy Of Its Branded Strains For Conditions Such As PTSD, Insomnia, Back Pain, IBS

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) released promising results Thursday of a survey that evaluated the effectiveness of seven company-branded medical cannabis strains in treating seven health conditions. read more

The Flowr Corp. To Export Up To 500KG Of Medical Cannabis To Israel

The Flowr Corporation (OTCQX: FLWPF) will export up to 500 kilos of premium dry cannabis flower in bulk into Israel. The move follows the company's recent announcement that it had raised $15.9 million by selling units. read more

IM Cannabis To Debut On NASDAQ

IM Cannabis Corp. (CSE: IMCC) has filed an application to list on NASDAQ Capital Market. The Israeli-based company would list its common shares under the trading symbol "IMCC." In addition, the shares would remain listed on the Canadian Securities Exchange as well, under the same trading symbol. read more